RANI

1.47

3.92% -0.06

Handel nachbörslich: 1.48 0.01 +0.68%

Rani Therapeutics Holdings Inc (RANI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.53

Offen:

$1.54

24-Stunden-Volumen:

462.13K

Relative Volume:

0.49

Marktkapitalisierung:

$48.63M

Einnahmen:

$3.04M

Nettoeinkommen (Verlust:

$-33.97M

KGV:

-1.1053

EPS:

-1.33

Netto-Cashflow:

$-52.47M

1W Leistung:

-3.29%

1M Leistung:

+8.09%

6M Leistung:

-50.34%

1J Leistung:

-60.16%

1-Tages-Spanne:

$1.4101

$1.54

1-Wochen-Bereich:

$1.4101

$1.58

52-Wochen-Spanne:

$1.24

$8.75

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Firmenname

Rani Therapeutics Holdings Inc

Sektor

Healthcare (1189)

Branche

Biotechnology (682)

Telefon

(408) 457-3700

Adresse

2051 RINGWOOD AVENUE, SAN JOSE

Mitarbeiter

140

Twitter

Nächster Verdiensttermin

2024-11-08

Neueste SEC-Einreichungen

RANI's Discussions on Twitter

Vergleichen Sie RANI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RANI Rani Therapeutics Holdings Inc	1.47	48.63M	3.04M	-33.97M	-52.47M	-1.33
VRTX Vertex Pharmaceuticals Inc	483.31	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	75.07B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.79B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	27.34B	3.30B	-501.07M	1.03B	-2.1146

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-02	Eingeleitet	Oppenheimer	Outperform
2024-06-14	Eingeleitet	Maxim Group	Buy
2024-06-13	Eingeleitet	Rodman & Renshaw	Buy
2023-04-17	Fortgesetzt	BTIG Research	Buy
2022-10-11	Eingeleitet	UBS	Buy
2022-07-27	Eingeleitet	H.C. Wainwright	Buy
2022-06-13	Eingeleitet	Wedbush	Outperform

Alle ansehen

Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten

Mar 01, 2025

Rani Therapeutics’ (RANI) Buy Rating Reiterated at Canaccord Genuity Group - Defense World

Mar 01, 2025

Feb 27, 2025

Canaccord Genuity Group Reiterates Buy Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat

Feb 27, 2025

Feb 15, 2025

Power to the People: How Individual Investors Shape Rani Therapeutics - Smartphone Magazine

Feb 15, 2025

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week - Yahoo Finance

Feb 15, 2025

Feb 14, 2025

RANI Shares Experience Surge in Value - Knox Daily

Feb 14, 2025

Janney Montgomery Scott LLC Buys New Position in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) - Defense World

Feb 14, 2025

Feb 12, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Feb 12, 2025

Feb 11, 2025

Rani Therapeutics (NASDAQ:RANI) Given Buy Rating at HC Wainwright - MarketBeat

Feb 11, 2025

Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $12.33 - Defense World

Feb 11, 2025

Feb 10, 2025

Analyzing PSQ Holdings Inc (PSQH) After Recent Trading Activity - Knox Daily

Feb 10, 2025

Rani Therapeutics’ (RANI) Buy Rating Reiterated at HC Wainwright - Defense World

Feb 10, 2025

These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Asianet Newsable

Feb 10, 2025

Feb 08, 2025

Rani Therapeutics (NASDAQ:RANI) Shares Up 0.7%Time to Buy? - MarketBeat

Feb 08, 2025

Rani Therapeutics (NASDAQ:RANI) Receives “Buy” Rating from HC Wainwright - Armenian Reporter

Feb 08, 2025

Feb 07, 2025

Was there any good news for Rani Therapeutics Holdings Inc (RANI) stock in the last session? - US Post News

Feb 07, 2025

Is Rani Therapeutics Holdings (NASDAQ:RANI) Using Too Much Debt? - Simply Wall St

Feb 07, 2025

Feb 06, 2025

Market cap of Tantech Holdings Ltd [TANH] reaches 1.11M – now what? - The DBT News

Feb 06, 2025